This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jean-Christophe Hoflack: Innovator in Oligonucleotide Research
Introduction
Jean-Christophe Hoflack is a notable inventor based in Saint-Louis, France. He has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotides.
Latest Patents
Hoflack holds a patent titled "Oligonucleotides for Modulating RTEL1 Expression." This patent reflects his innovative approach to genetic modulation and its potential applications in therapeutic settings. He has 1 patent to his name.
Career Highlights
Hoflack is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company focuses on advancing research in molecular biology and genetics.
Collaborations
Throughout his career, Hoflack has collaborated with esteemed colleagues, including Brian Leonard and Miriam Triyatni. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Jean-Christophe Hoflack's contributions to oligonucleotide research exemplify the innovative spirit of modern biotechnology. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile